Alzheimer's disease is a neurodegenerative brain disease that kills neurons. The global prevalence of the disease is gradually growing. In all leading countries, it is one of the senior citizens' leading causes of death. So, much research shows that early detection of illness is the most critical factor in improving patient care and treatment outcomes. Currently, AD is diagnosed by the manual study of magnetic resonance imaging, biomarker tests, and cognitive tests. Machine learning algorithms are used for automatic diagnosis. However, they have certain limits in terms of accuracy. Another issue is that models trained on class-unbalanced datasets often have poor results. Therefore, the main objective of the proposed work is to include a pre-processing method before the hybrid model to improve classification accuracy. This research presents a hybrid model based on a deep learning approach to detect Alzheimer’s disease. Which, we are using the SMOTE method to equally distribute the classes to prevent the issue of class imbalance. The hybrid model uses Inception V3 and Resnet50 to detect characteristics of Alzheimer's disease from magnetic resonance imaging. Finally, a dense layer of convolution neural network is used for classification. The hybrid approach achieves 99% accuracy in classifying MRI datasets, which is better than the old work. These results are better than existing approaches based on accuracy, specificity, sensitivity, and other characteristics.
{"title":"Hybrid Model: Deep Learning method for Early Detection of Alzheimer’s disease from MRI images","authors":"Anuradha Vashishtha, Anuja Kumar Acharya, Sujata Swain","doi":"10.13005/bpj/2739","DOIUrl":"https://doi.org/10.13005/bpj/2739","url":null,"abstract":"Alzheimer's disease is a neurodegenerative brain disease that kills neurons. The global prevalence of the disease is gradually growing. In all leading countries, it is one of the senior citizens' leading causes of death. So, much research shows that early detection of illness is the most critical factor in improving patient care and treatment outcomes. Currently, AD is diagnosed by the manual study of magnetic resonance imaging, biomarker tests, and cognitive tests. Machine learning algorithms are used for automatic diagnosis. However, they have certain limits in terms of accuracy. Another issue is that models trained on class-unbalanced datasets often have poor results. Therefore, the main objective of the proposed work is to include a pre-processing method before the hybrid model to improve classification accuracy. This research presents a hybrid model based on a deep learning approach to detect Alzheimer’s disease. Which, we are using the SMOTE method to equally distribute the classes to prevent the issue of class imbalance. The hybrid model uses Inception V3 and Resnet50 to detect characteristics of Alzheimer's disease from magnetic resonance imaging. Finally, a dense layer of convolution neural network is used for classification. The hybrid approach achieves 99% accuracy in classifying MRI datasets, which is better than the old work. These results are better than existing approaches based on accuracy, specificity, sensitivity, and other characteristics.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135031876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zeba Siddiqui, Mohammad Irfan Khan, Badruddeen Badruddeen, Juber Akhtar, Mohammad Ahmed
Background: For safe and efficacious use of natural products, quality control of the crude drug is of paramount importance. Due to lack of scientific investigations pertaining to quality control phytochemical and pharmacological properties of Phyllanthus acidus (L.) Skeels, the present study was undertaken. Objective: The aim of the study is to establish various pharmacognostical and phytochemical parameters, including both macro and microscopic studies, along with HPTLC and FTIR fingerprinting analysis, total phenolic and flavonoid content of stem bark of Phyllanthus acidus, followed by exploring its anti-oxidant potential. Method: The determination of total phenolic and flavonoid content was done by various colorimetric assays. DPPH assay was used to establish antioxidant activity. Physiochemical analysis was carried out and presence of various functional groups was determined using various techniques like HPTLC, FTIR analysis and colorimetric assays. Result: The phytochemical screening showed the presence of various phytoconstituents like phenols, carbohydrates, flavonoid, tannins and terpenoids. in various solvent systems. Total phenolic was established as 189.74±0.52mg GAE/g and flavonoid content was found to be38.92±0.47 mg QE/g. Concentration of heavy metal was within acceptable limits. The stem bark showed comparable antioxidant activity in methanolic and aqueous extract showed IC50 values of 26.92 and 26.52 respectively compared to ascorbic acid having IC50 value of 31.82. HPTLC fingerprinting envisaged the presence of several phytoconstituents in Phyllanthus acidus. The FTIR analysis established the presence of phenolic functional groups. Conclusion: The referential information provided by this study will be useful to determine and manage adulterations in raw material. The study also provides insight into antioxidant property of this plant validating its ethno pharmacological use as a natural antioxidant.
{"title":"In Vitro Antioxidant Activity, Pharmacognostical Evaluation, HPTLC and FTIR Fingerprinting of Phyllanthus Acidus L. Stem Bark Extract for Better Application in Phytotherapy","authors":"Zeba Siddiqui, Mohammad Irfan Khan, Badruddeen Badruddeen, Juber Akhtar, Mohammad Ahmed","doi":"10.13005/bpj/2716","DOIUrl":"https://doi.org/10.13005/bpj/2716","url":null,"abstract":"Background: For safe and efficacious use of natural products, quality control of the crude drug is of paramount importance. Due to lack of scientific investigations pertaining to quality control phytochemical and pharmacological properties of Phyllanthus acidus (L.) Skeels, the present study was undertaken. Objective: The aim of the study is to establish various pharmacognostical and phytochemical parameters, including both macro and microscopic studies, along with HPTLC and FTIR fingerprinting analysis, total phenolic and flavonoid content of stem bark of Phyllanthus acidus, followed by exploring its anti-oxidant potential. Method: The determination of total phenolic and flavonoid content was done by various colorimetric assays. DPPH assay was used to establish antioxidant activity. Physiochemical analysis was carried out and presence of various functional groups was determined using various techniques like HPTLC, FTIR analysis and colorimetric assays. Result: The phytochemical screening showed the presence of various phytoconstituents like phenols, carbohydrates, flavonoid, tannins and terpenoids. in various solvent systems. Total phenolic was established as 189.74±0.52mg GAE/g and flavonoid content was found to be38.92±0.47 mg QE/g. Concentration of heavy metal was within acceptable limits. The stem bark showed comparable antioxidant activity in methanolic and aqueous extract showed IC50 values of 26.92 and 26.52 respectively compared to ascorbic acid having IC50 value of 31.82. HPTLC fingerprinting envisaged the presence of several phytoconstituents in Phyllanthus acidus. The FTIR analysis established the presence of phenolic functional groups. Conclusion: The referential information provided by this study will be useful to determine and manage adulterations in raw material. The study also provides insight into antioxidant property of this plant validating its ethno pharmacological use as a natural antioxidant.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135031936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sri Rahayu Santi, I Made Sukadana, I Gusti Agung Gede Bawa, Novi Tamauli Herawati Simalango
This study aimed to screen the antibacterial compounds of S. aureus and E. coli on the stem bark of Inocarpus fagiferus Fosb. Extraction of active antibacterial compounds by maceration and partitioning, antibacterial tests were carried out by diffusion method, separation of compounds by column chromatography method, and identification of active fractions using LSMS/MS. The results of maceration of 350 g of Inocarpus fagiferus Fosb stem bark produced 22.97 g of methanol viscous extract which was able to strongly inhibit the growth of S. aureus bacteria (14.75mm) and medium inhibit (8.50 mm) towards E. coli. The partition results of the methanol concentrated extract respectively with n-hexane, chloroform, n-butanol, and water yielded 0.01; 0.01; 2.75, and 0.07 g extracts. Based on extract weight only n-butanol extract allows further separation. The result of antibacterial activity has shown a strong inhibition zone toward S. aureus and E. coli (16.50 mm) and with a minimum inhibitory concentration (MIC) of 5%. The result of separation n-butanol extract by gradient column chromatography (silica gel 60; methanol: chloroform (5:5; 6:4; 7:3; 8:4; 9:1; and 10:0)) yielded 4 fractions (FA, FB, FC, and FD) with FC the most active antibacterial toward S. aureus and E. coli with an inhibition zone 7.25 mm and 6.25 mm respectively at 5%. The results of LCMS/MS show 5 identified compounds known are maltol, nicotinamide, bioachanin A, L-proline, and 2,3-diamino propionic acid, as well as one unidentified compound with a molecular weight of 95.8066 g/mol. Maltol, nicotinamide, bioachanin A, and L-proline are compounds potents to inhibit the growth of S. aureus and E. coli bacteria.
{"title":"Antibacterial Compounds Towards Staphylococcus aureus and Escherichia coli of the Stem Bark of Inocarpus Fagigerus FoSB","authors":"Sri Rahayu Santi, I Made Sukadana, I Gusti Agung Gede Bawa, Novi Tamauli Herawati Simalango","doi":"10.13005/bpj/2743","DOIUrl":"https://doi.org/10.13005/bpj/2743","url":null,"abstract":"This study aimed to screen the antibacterial compounds of S. aureus and E. coli on the stem bark of Inocarpus fagiferus Fosb. Extraction of active antibacterial compounds by maceration and partitioning, antibacterial tests were carried out by diffusion method, separation of compounds by column chromatography method, and identification of active fractions using LSMS/MS. The results of maceration of 350 g of Inocarpus fagiferus Fosb stem bark produced 22.97 g of methanol viscous extract which was able to strongly inhibit the growth of S. aureus bacteria (14.75mm) and medium inhibit (8.50 mm) towards E. coli. The partition results of the methanol concentrated extract respectively with n-hexane, chloroform, n-butanol, and water yielded 0.01; 0.01; 2.75, and 0.07 g extracts. Based on extract weight only n-butanol extract allows further separation. The result of antibacterial activity has shown a strong inhibition zone toward S. aureus and E. coli (16.50 mm) and with a minimum inhibitory concentration (MIC) of 5%. The result of separation n-butanol extract by gradient column chromatography (silica gel 60; methanol: chloroform (5:5; 6:4; 7:3; 8:4; 9:1; and 10:0)) yielded 4 fractions (FA, FB, FC, and FD) with FC the most active antibacterial toward S. aureus and E. coli with an inhibition zone 7.25 mm and 6.25 mm respectively at 5%. The results of LCMS/MS show 5 identified compounds known are maltol, nicotinamide, bioachanin A, L-proline, and 2,3-diamino propionic acid, as well as one unidentified compound with a molecular weight of 95.8066 g/mol. Maltol, nicotinamide, bioachanin A, and L-proline are compounds potents to inhibit the growth of S. aureus and E. coli bacteria.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135032058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Manoharan, Shreya Srinivasan, Vignesh NR, Aswin Senthilvel
The most frequently prescribed antibiotic class in dermatology is the tetracycline family, which has both antibacterial and anti-inflammatory characteristics. Tetracycline is a broad-spectrum polyketide antibiotic effective against gram-positive and gram-negative organisms. It has been accepted for the therapeutic use of various conditions in dermatology like Acne, Rosacea, Syphilis, Immuno-bullous dermatoses, Pyoderma gangrenosum and Hidradenitis Suppurativa to name a few. However, the use and efficacy of newly discovered tetracyclines like Sarecycline, Omadacycline and Tigecycline are still yet to be documented and researched. In this study, a short summary of the utilization of various tetracycline are being documented for their use in dermatology.
{"title":"Tetracyclines: The Old, the New and the Improved - A Short Review","authors":"D. Manoharan, Shreya Srinivasan, Vignesh NR, Aswin Senthilvel","doi":"10.13005/bpj/2722","DOIUrl":"https://doi.org/10.13005/bpj/2722","url":null,"abstract":"The most frequently prescribed antibiotic class in dermatology is the tetracycline family, which has both antibacterial and anti-inflammatory characteristics. Tetracycline is a broad-spectrum polyketide antibiotic effective against gram-positive and gram-negative organisms. It has been accepted for the therapeutic use of various conditions in dermatology like Acne, Rosacea, Syphilis, Immuno-bullous dermatoses, Pyoderma gangrenosum and Hidradenitis Suppurativa to name a few. However, the use and efficacy of newly discovered tetracyclines like Sarecycline, Omadacycline and Tigecycline are still yet to be documented and researched. In this study, a short summary of the utilization of various tetracycline are being documented for their use in dermatology.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135032370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stefano Mastrangelo, Giorgio Attina, Antonio Ruggiero
Some multithyrosine kinase inhibitors have been reported to cause changes in thyroid function. For the management of sunitinib-induced hypothyroidism, an evaluation of thyroid hormone and antibody profile is recommended before starting treatment with tyrosine kinase inhibitors. Patients with pre-existing thyroid dysfunction should undergo dose adjustment of L-thyroxine during treatment with tyrosine kinase inhibitors. Thyroid dysfunction is not a reason to discontinue or reduce the dosage of sunitinib. Their occurrence appears to correlate with increased antitumour efficacy of the inhibitor. There are currently no guidelines for monitoring thyroid activity during treatment with TKIs, and the time interval at which TSH should be periodically measured has not yet been determined. A reasonable approach is to monitor thyroid function, both before and during 2-4 weeks after the end of therapy. A comprehensive analysis of adverse events associated with the use of these inhibitors could help clinical monitoring of patients along with the adoption of appropriate management approaches.
{"title":"Tyrosine Kinase Inhibitors and Thyroid Toxicity","authors":"Stefano Mastrangelo, Giorgio Attina, Antonio Ruggiero","doi":"10.13005/bpj/2713","DOIUrl":"https://doi.org/10.13005/bpj/2713","url":null,"abstract":"Some multithyrosine kinase inhibitors have been reported to cause changes in thyroid function. For the management of sunitinib-induced hypothyroidism, an evaluation of thyroid hormone and antibody profile is recommended before starting treatment with tyrosine kinase inhibitors. Patients with pre-existing thyroid dysfunction should undergo dose adjustment of L-thyroxine during treatment with tyrosine kinase inhibitors. Thyroid dysfunction is not a reason to discontinue or reduce the dosage of sunitinib. Their occurrence appears to correlate with increased antitumour efficacy of the inhibitor. There are currently no guidelines for monitoring thyroid activity during treatment with TKIs, and the time interval at which TSH should be periodically measured has not yet been determined. A reasonable approach is to monitor thyroid function, both before and during 2-4 weeks after the end of therapy. A comprehensive analysis of adverse events associated with the use of these inhibitors could help clinical monitoring of patients along with the adoption of appropriate management approaches.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135032538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Basavaraj Poojar, Ashok Shenoy K, Ashwin Kamath, John Ramapuram, Sathish B. Rao, Sheetal Dinkar Ullal
Overall literacy talents comprise an individual’s capacity to read, write and recognise written information (print literacy), articulate and interpret oral language (oral literacy) and interpret and apply for numbers in everyday activities (numeracy). Health literacy, a subset of overall literacy talents, is relatively correlated with it and has been described as the extent to which people can gain, approach, and understand introductory medical information and services required to take health decisions. Concerning HIV, people with low health literacy have less information on the illness and their medical care needs. Moreover, they show poor drug compliance, potentially leading to treatment failure and lack of achievement of the target viral load reduction. The shortfall of non-conceptual models of health literacy is an issue in the utilization of general proficiency instruments. HIV disease-specific health literacy instruments would be more useful and likely to provide more meaningful results rather than those obtained through the use of general instruments. Further exploration of HIV health literacy is demanded. Prospective studies should involve different geographical areas with different socioeconomic characteristics, societal structures and regional healthcare settings. This narrative review has limitations. The vast majority of the HIV research referenced in this study was conducted among the western and African populations with HIV. The studies generally excluded individuals over 50 years of age, restricting the applicability of the study findings.
{"title":"Health Literacy in People Living with Human Immunodeficiency Virus Infection: A Narrative Review","authors":"Basavaraj Poojar, Ashok Shenoy K, Ashwin Kamath, John Ramapuram, Sathish B. Rao, Sheetal Dinkar Ullal","doi":"10.13005/bpj/2726","DOIUrl":"https://doi.org/10.13005/bpj/2726","url":null,"abstract":"Overall literacy talents comprise an individual’s capacity to read, write and recognise written information (print literacy), articulate and interpret oral language (oral literacy) and interpret and apply for numbers in everyday activities (numeracy). Health literacy, a subset of overall literacy talents, is relatively correlated with it and has been described as the extent to which people can gain, approach, and understand introductory medical information and services required to take health decisions. Concerning HIV, people with low health literacy have less information on the illness and their medical care needs. Moreover, they show poor drug compliance, potentially leading to treatment failure and lack of achievement of the target viral load reduction. The shortfall of non-conceptual models of health literacy is an issue in the utilization of general proficiency instruments. HIV disease-specific health literacy instruments would be more useful and likely to provide more meaningful results rather than those obtained through the use of general instruments. Further exploration of HIV health literacy is demanded. Prospective studies should involve different geographical areas with different socioeconomic characteristics, societal structures and regional healthcare settings. This narrative review has limitations. The vast majority of the HIV research referenced in this study was conducted among the western and African populations with HIV. The studies generally excluded individuals over 50 years of age, restricting the applicability of the study findings.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135031748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study examined the future of Mahoni seed as an aspirant drug for treating diabetes. Mahogany seeds were washed using n-hexane solvent and followed by ethanol solvent. Extracts were measured using a standard spectrophotometric plate reader with acarbose (Glucobayâ). Glucose tolerance was tested in alloxan-challenged mice. The results indicated that the extract had potency against a-glucosidases inhibited through a non-competitive mechanism. The IC50 value of the extract is 4.7 μg/ml, which was lower than 5.7 μg/ml for acarbose and has less activity on glucose tolerance at doses of 120 and 240 mg/kg. As a conclution, purified mahogany seed extract got the ability to be developed as a new antidiabetic drug candidate.
{"title":"In Vivo and In Vitro Antidiabetic Assay of Purified Mahoni Seeds Extract (Swietenia mahagoni (L.) Jacq)","authors":"Aktsar Roskiana Ahamd, Abd. Malik, Virsa Handayani","doi":"10.13005/bpj/2748","DOIUrl":"https://doi.org/10.13005/bpj/2748","url":null,"abstract":"This study examined the future of Mahoni seed as an aspirant drug for treating diabetes. Mahogany seeds were washed using n-hexane solvent and followed by ethanol solvent. Extracts were measured using a standard spectrophotometric plate reader with acarbose (Glucobayâ). Glucose tolerance was tested in alloxan-challenged mice. The results indicated that the extract had potency against a-glucosidases inhibited through a non-competitive mechanism. The IC50 value of the extract is 4.7 μg/ml, which was lower than 5.7 μg/ml for acarbose and has less activity on glucose tolerance at doses of 120 and 240 mg/kg. As a conclution, purified mahogany seed extract got the ability to be developed as a new antidiabetic drug candidate.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135031889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Widjiati Widjiati, Suryo Kuntjorodjakti, Aditya Tri Ananda, Mey Vanda Pusparina Sajida, Alivia Fairuz Ilmi, Meisa Zalfa Adisti, Dean Chou, Epy Muhammad Luqman
Livestock that has stress releases glucocorticoids in response to it, and it causes inhibition of the hypothalamus-pituitary-gonadal axis (HPG) signaling pathway so that it reduces reproductive efficiency. Forest honey can reduce corticosteroid levels as a stress response from physical stress induction which is expected to increase reproductive efficiency including folliculogenesis and the formation of the corpus luteum. This study aims to determine the effect of forest honey on rats (Rattus novergicus) exposed to physical stress on corticosteroid levels, folliculogenesis, and the number of corpus luteum. This study is an experimental laboratory one using 32 rats which were divided into 4 treatment groups; control positive (C) treated with physical stress, treatment 1 (T1) treated with physical stress + honey 2 g/rat/day PO, treatment 2 (T2) treated with physical stress + honey 4 g/rat/day PO and treatment 3 (T3) treated with physical stress + honey 6 g/rat/day PO. All treatments were carried out for 14 days. The results showed that T1 had the lowest corticosteroid level compared to all treatment groups and the corticosteroid level of this group was significantly different (p <0.05) compared to that of C and T3. The folliculogenesis profile showed that the number of primary secondary, tertiary, and Graafian follicles of group T1 was significantly different (p<0.05) compared to that of C, T2, and T3. In terms of the number of corpus luteum, it showed that T1 had the highest number of corpus luteum, and the number of corpus luteum in this group was significantly different (p<0.05) from that of C, T2, and T3. It can be concluded that the administration of forest honey at a dose of 2g/rat/day could reduce corticosteroid levels, improve the folliculogenesis profile, and increase the number of corpus luteum in rats exposed to physical stress. The use of forest honey could reduce corticosteroid levels as a stress response from physical stress induction which was expected to increase reproductive efficiency.
{"title":"The Effect of Administering Forest Honey to Rats Exposed to Physical Stress on Corticosteroid Levels, Folliculogenesis and the Number of Corpus Luteum","authors":"Widjiati Widjiati, Suryo Kuntjorodjakti, Aditya Tri Ananda, Mey Vanda Pusparina Sajida, Alivia Fairuz Ilmi, Meisa Zalfa Adisti, Dean Chou, Epy Muhammad Luqman","doi":"10.13005/bpj/2721","DOIUrl":"https://doi.org/10.13005/bpj/2721","url":null,"abstract":"Livestock that has stress releases glucocorticoids in response to it, and it causes inhibition of the hypothalamus-pituitary-gonadal axis (HPG) signaling pathway so that it reduces reproductive efficiency. Forest honey can reduce corticosteroid levels as a stress response from physical stress induction which is expected to increase reproductive efficiency including folliculogenesis and the formation of the corpus luteum. This study aims to determine the effect of forest honey on rats (Rattus novergicus) exposed to physical stress on corticosteroid levels, folliculogenesis, and the number of corpus luteum. This study is an experimental laboratory one using 32 rats which were divided into 4 treatment groups; control positive (C) treated with physical stress, treatment 1 (T1) treated with physical stress + honey 2 g/rat/day PO, treatment 2 (T2) treated with physical stress + honey 4 g/rat/day PO and treatment 3 (T3) treated with physical stress + honey 6 g/rat/day PO. All treatments were carried out for 14 days. The results showed that T1 had the lowest corticosteroid level compared to all treatment groups and the corticosteroid level of this group was significantly different (p <0.05) compared to that of C and T3. The folliculogenesis profile showed that the number of primary secondary, tertiary, and Graafian follicles of group T1 was significantly different (p<0.05) compared to that of C, T2, and T3. In terms of the number of corpus luteum, it showed that T1 had the highest number of corpus luteum, and the number of corpus luteum in this group was significantly different (p<0.05) from that of C, T2, and T3. It can be concluded that the administration of forest honey at a dose of 2g/rat/day could reduce corticosteroid levels, improve the folliculogenesis profile, and increase the number of corpus luteum in rats exposed to physical stress. The use of forest honey could reduce corticosteroid levels as a stress response from physical stress induction which was expected to increase reproductive efficiency.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135032270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vitis pedata is a woody climber of the Vitaceae family with a multitude of pharmacological effects like anti-inflammatory, antibacterial, anti-nociceptive, anti-arthritic, anti-oxidant, astringent, and hemostatic qualities. The research targets to assess the anti-diabetic efficacy of Vitis pedata aqueous extract nanoformulation in alloxan-induced diabetes rats. Biocompatible polycationic polymer chitosan is used for nanoformulation development. The aqueous extract loaded chitosan nanoparticle formulation displayed a particle size of 186± 5.37 nm with a polydispersity index of 0.226 and zeta potential value of 23 ± 1.93 mV. The nanoformulations were assessed for its anti-diabetic properties in comparison to aqueous extracts for the first time by in- vivo methodologies. Several parameters like body weight, blood glucose level, blood and serum biomarkers, were examined. Changes in tissue histoarchitecture, liver glycogen content, oxidative stress response and antioxidant status were also studied. In diabetic rats, the nano-scale formulation significantly reduced blood glucose levels, glucose tolerance, lipid profiles, and serum biomarkers, comparable to the oral hypoglycemic medication glibenclamide. The restoration of antioxidant status and pancreatic histoarchitecture through by size assisted delivery may be related to the improved control of diabetes by the nanoformulation than the extract alone. The work marks the first report of Vitis pedata nanoformulation for diabetes management and can serve as a prelude for further preclinical/clinical evaluations.
{"title":"Vitis Pedata Nanoformulation in the Management of Alloxan Induced Experimental Diabetes","authors":"Suvadra Das, Joyeeta Bhattacharya, Srija Sur, Subhasis Chakraborty, Aparna Lakshmi, Tanay Pramanik, Partha Roy","doi":"10.13005/bpj/2715","DOIUrl":"https://doi.org/10.13005/bpj/2715","url":null,"abstract":"Vitis pedata is a woody climber of the Vitaceae family with a multitude of pharmacological effects like anti-inflammatory, antibacterial, anti-nociceptive, anti-arthritic, anti-oxidant, astringent, and hemostatic qualities. The research targets to assess the anti-diabetic efficacy of Vitis pedata aqueous extract nanoformulation in alloxan-induced diabetes rats. Biocompatible polycationic polymer chitosan is used for nanoformulation development. The aqueous extract loaded chitosan nanoparticle formulation displayed a particle size of 186± 5.37 nm with a polydispersity index of 0.226 and zeta potential value of 23 ± 1.93 mV. The nanoformulations were assessed for its anti-diabetic properties in comparison to aqueous extracts for the first time by in- vivo methodologies. Several parameters like body weight, blood glucose level, blood and serum biomarkers, were examined. Changes in tissue histoarchitecture, liver glycogen content, oxidative stress response and antioxidant status were also studied. In diabetic rats, the nano-scale formulation significantly reduced blood glucose levels, glucose tolerance, lipid profiles, and serum biomarkers, comparable to the oral hypoglycemic medication glibenclamide. The restoration of antioxidant status and pancreatic histoarchitecture through by size assisted delivery may be related to the improved control of diabetes by the nanoformulation than the extract alone. The work marks the first report of Vitis pedata nanoformulation for diabetes management and can serve as a prelude for further preclinical/clinical evaluations.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135032537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tahani H Ibrahim, Sara Almutiri, Manahil Alharbi, Dana Alotaibi, Mehboob Ali, Waleed Hamza, Mohamed Zaki
Acute coronary syndrome (ACS) which known as subcategory of coronary heart disease is considered a major cause of death. In Saudi Arabia, the prevalence of ACS is 8.2%. Early recognition of risk factors (RFs) associated with ACS is essential to prevent its progression. Therefore, the goals of this study is to estimate the prevalence of cardiovascular RFs among ACS patients and to appraise its association with the development of ACS. This retrospective multi-center cross-sectional study involved 170 patients admitted to Prince Sultan cardiac center, King Saud Hospital, and Bukayriyah General Hospital in Al Qassim, KSA. The participants categorized into three groups UA, NSTEMI, and STEMI. Patients with stable angina or previous MI were excluded from the study. 73.5% were males and 26.5% were females with a mean age of 58.2 ± 11.9. The distribution of ACS subtypes was 51.2%, 27.6%, and 21.2% for STEMI, NSTEMI and UA, respectively. The most common RFs were diabetes mellitus (DM), hypertension (66% each), and dyslipidemia (58%). The prevalence of RFs among STEMI group was 65.6% active smokers, 54.5% dyslipidemia, and 52.2% ischemic heart disease (IHD). On the other hand, in NSTEMI group hypertension and DM were nearly the same (32% & 30% respectively), however family history of IHD was 42.9%. UA revealed a strong association with IHD and family history of IHD (30.4%, 28.6%, respectively).To conclude, most of ACS patients presented with STEMI followed by NSTEMI and the least with UA. Among the cardiovascular risk factors, HTN, DM, and dyslipidemia, were presented in more than half of the patients which strongly suggests an association with developing ACS.
{"title":"Relationship between Cardiovascular Risk Factors and Development of Acute Coronary Syndrome","authors":"Tahani H Ibrahim, Sara Almutiri, Manahil Alharbi, Dana Alotaibi, Mehboob Ali, Waleed Hamza, Mohamed Zaki","doi":"10.13005/bpj/2756","DOIUrl":"https://doi.org/10.13005/bpj/2756","url":null,"abstract":"Acute coronary syndrome (ACS) which known as subcategory of coronary heart disease is considered a major cause of death. In Saudi Arabia, the prevalence of ACS is 8.2%. Early recognition of risk factors (RFs) associated with ACS is essential to prevent its progression. Therefore, the goals of this study is to estimate the prevalence of cardiovascular RFs among ACS patients and to appraise its association with the development of ACS. This retrospective multi-center cross-sectional study involved 170 patients admitted to Prince Sultan cardiac center, King Saud Hospital, and Bukayriyah General Hospital in Al Qassim, KSA. The participants categorized into three groups UA, NSTEMI, and STEMI. Patients with stable angina or previous MI were excluded from the study. 73.5% were males and 26.5% were females with a mean age of 58.2 ± 11.9. The distribution of ACS subtypes was 51.2%, 27.6%, and 21.2% for STEMI, NSTEMI and UA, respectively. The most common RFs were diabetes mellitus (DM), hypertension (66% each), and dyslipidemia (58%). The prevalence of RFs among STEMI group was 65.6% active smokers, 54.5% dyslipidemia, and 52.2% ischemic heart disease (IHD). On the other hand, in NSTEMI group hypertension and DM were nearly the same (32% & 30% respectively), however family history of IHD was 42.9%. UA revealed a strong association with IHD and family history of IHD (30.4%, 28.6%, respectively).To conclude, most of ACS patients presented with STEMI followed by NSTEMI and the least with UA. Among the cardiovascular risk factors, HTN, DM, and dyslipidemia, were presented in more than half of the patients which strongly suggests an association with developing ACS.","PeriodicalId":9054,"journal":{"name":"Biomedical and Pharmacology Journal","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135032691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：